Imidazo[1,2-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors

Details for Australian Patent Application No. 2008323287 (hide)

Owner Ortho-McNeil-Janssen Pharmaceuticals, Inc. Addex Pharma S.A.

Inventors Tresadern, Gary John; Cid-Nunez, Jose Maria; Trabanco-Suarez, Andres Avelino; Vega Ramiro, Juan Antonio

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2008323287

PCT Pub. Number WO2009/062676

Priority 07120647.8 14.11.07 EP

Filing date 12 November 2008

Wipo publication date 22 May 2009

Acceptance publication date 14 July 2011

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/437 (2006.01)

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 519/00 (2006.01) Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or

Event Publications

3 June 2010 PCT application entered the National Phase

  PCT publication WO2009/062676 Priority application(s): WO2009/062676

14 July 2011 Application Accepted

  Published as AU-B-2008323287

10 November 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008323303-Brewing process and brewery installations

2008323239-Method for producing regenerated biopolymers and regenerated products obtained by said method